Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence

Levonadifloxacin and its prodrug alalevonadifloxacin are novel broad-spectrum anti-MRSA agents belonging to the benzoquinolizine subclass of quinolone, formulated for intravenous and oral administration, respectively. Various in vitro and in vivo studies have established their antimicrobial spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhagwat, Sachin S, Nandanwar, Manohar, Kansagara, Atul, Patel, Anusuya, Takalkar, Swapna, Chavan, Rajesh, Periasamy, Hariharan, Yeole, Ravindra, Deshpande, Prasad K, Bhavsar, Satish, Bhatia, Ashima, Ahdal, Jaishid, Jain, Rishi, Patel, Mahesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935279/
https://www.ncbi.nlm.nih.gov/pubmed/31920285
http://dx.doi.org/10.2147/DDDT.S229882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935279/
https://www.ncbi.nlm.nih.gov/pubmed/31920285
http://dx.doi.org/10.2147/DDDT.S229882

Ejemplares similares